Anyone can develop lung cancer — even those who’ve never smoked. From radon to air pollution, hidden risks matter. Learn what causes lung cancer in non-smokers and how early detection saves lives. 🔗 Read more: buff.ly/20s2nyY #LungCancerAwareness #EarlyDetection #CizzleBio

Cizzle Bio is attending #AVBCC2025 in NYC! 🗽 Our CEO, Bill Behnke, will moderate: “Advancing Cancer Diagnostics to Commercialization”—a panel exploring the pathway of delivering innovative diagnostics in value-based care. 🗓️ Oct 22–24 📍 New York Athletic Club 🔗 buff.ly/wtq6ujH #CizzleBio #Biotech

Too young for lung cancer? The truth may surprise you. Rates are rising among younger adults; many never smoked. Learn why awareness and early detection with the CIZ1B biomarker blood test are critical. 🔗 Read more: buff.ly/ZWbnQ1H #EarlyDetection #LungCancerAwareness #CizzleBio

Excited to share that Cizzle Bio is attending the Global Cancer Research and Innovation Symposium on October 21 in NYC! We’ll be engaging with industry leaders to discuss our CIZ1B and DEX-G2 blood tests for early cancer detection. 🔗 buff.ly/d3cqA8z #CizzleBio #GCRIS2025 #Biotech #CancerResearch

🌍 It’s World Lung Day. At Cizzle Bio, we’re advancing blood tests that detect lung cancer early—when survival rates are highest. 💚 Together, let’s make early detection the standard of care.#WorldLungDay #DetectEarlySaveLives #CizzleBio #medsky

🌍 Today is #WorldCancerResearchDay. We stand with researchers worldwide advancing cancer prevention, detection & treatment. At Cizzle Bio, we’re focused on early detection through biomarker science—because finding cancer early saves lives. 💚💙 #EarlyDetectionMatters #CizzleBio

We’re featured in Chief’s Digest! The article highlights how we’re transforming cancer detection with biomarker-based blood tests for early lung & gastric cancer detection. Read it here: buff.ly/aC1mc77 #DetectEarlySaveLives #CancerPrevention

📢 New Press Release: Cizzle Bio sponsored the Prevent Cancer Foundation® 40th Anniversary and Gala. Read how this milestone event reinforces our mission to make early detection the global standard of care. 🔗 buff.ly/QpLwpRd #DetectEarlySaveLives #CancerPrevention

Thank you @preventcancer.org for uniting such an inspiring community at this year’s Gala. We’re proud to sponsor and advance early detection with two simple blood tests – CIZ1B (lung) & DEX-G2 (gastric). #DetectEarlySaveLives #PreventCancerGala @inovahealth.bsky.social @lungevity.bsky.social

A night to remember at the @preventcancer.org Foundation® 40th Anniversary Gala ✨ Proud to celebrate innovation with leaders in research, advocacy & patient care - all united by one goal: early detection saves lives. #DetectEarlySaveLives #PreventCancerGala

We’re proud to support the @preventcancer.org Foundation® 40th Anniversary Gala - a powerful reminder that early detection saves lives. CIZ1B: early lung cancer detection DEX-G2: early gastric cancer detection #DetectEarlySaveLives #PreventCancerGala

Did you know radon gas is the 2nd leading cause of lung cancer in the U.S.? It’s invisible, odorless—and preventable. Testing your home can reduce risks and save lives. Read our new blog to learn more:

Exciting news: Dr. Mark Miglarese has joined Cizzle Bio as Senior Lab Advisor! With decades of leadership in oncology R&D and diagnostics, his expertise strengthens our mission to detect cancer early. Read more: buff.ly/Oq6ZpPp #CizzleBio #CancerResearch #EarlyDetection

Cizzle Bio is attending CHEST 2025 Annual Meeting in Chicago, Oct 19–22. This 90th anniversary event brings together the world’s top pulmonary and critical care experts. We’re proud to highlight CIZ1B, our blood test for early lung cancer detection (95% sensitivity, 96% NPV). buff.ly/BstOadd

Medical oncologist and clinical researcher Jessica Treviño Jones, M.D., is reshaping how and when we detect lung cancer. In a new blog with @CizzleBio, she explains why CIZ1B—a true biomarker test—offers a chance to catch cancer earlier when treatment is most effective. buff.ly/ARpC5l0

Cizzle Bio is proud to sponsor the @preventcancer.org, celebrating progress in early detection. Our blood tests (CIZ1B & DEX-G2) detect cancer early, when it’s most treatable. Learn more: www.cizzlebio.com #PreventCancerGala #EarlyDetection

Drea was told: “You’re too young for lung cancer.” She was 26. She had Stage 4 — in both lungs, her spine, and brain. 🫁 Lung cancer is the #1 cancer killer — and it’s rising in women under 50. We must listen. We must detect early. #CizzleBio #LungCancerAwareness #GenerationCancer

Cizzle Bio is proud to attend the 8th Annual AABIP Conference this August in Austin, TX. We’ll be engaging with leaders in pulmonology to discuss how our CIZ1B and DEX-G2 blood tests support early, accurate, and minimally invasive cancer detection. 🔗 buff.ly/foAKcMO

Published in JAMA Surgery Our DEX-G2 biomarker-based blood test shows 95% sensitivity and 96.8% accuracy for early gastric cancer detection. Validated across 809 samples in a major international study. 🔗 Read more: buff.ly/p8dnXQL #DEXG2 #EarlyDetection #CizzleBio

This #WorldLungCancerDay, we reaffirm our mission: Make early lung cancer detection accessible and affordable. CIZ1B is coming. Follow our journey. #CizzleBio #EarlyDetection

Lung cancer survival drops from 60% at Stage I to just 7% at Stage IV. Our CIZ1B blood test aims to catch it early—when it matters most. #WorldLungCancerDay #FightLungCancer #CizzleBio

Lung cancer kills more people than breast, prostate, and colon cancers combined. We’re working to change that—with a simple blood test for early detection. #WorldLungCancerDay #EarlyDetection #LungCancer #CizzleBio

🚨 Big news! We’ve submitted an NIH grant with IHMC & SwRI to validate our CIZ1B blood test for early lung cancer detection. This could help pinpoint when CIZ1B first signals disease across diverse groups. Read more: www.cizzlebio.com/press-releas... #CizzleBio #LungCancer #NIHGrant

Big news: Our CEO, Bill Behnke, is featured in CEO/CFO Magazine! “We’re making early detection more accessible—because when cancer is found early, lives can be saved.” Read more: ceocfointerviews.com/cizzlebio062... #CizzleBio #EarlyDetection #LungCancer #Biotech #CEOCFO

Cizzle Bio is headed to the 2025 BIO International Convention in Boston! 🧬 We’re building the future of early cancer detection with biomarker blood tests. Let’s connect June 16–19. Link: www.cizzlebio.com/events/bio-i... #BIO2025 #CizzleBio #CancerDetection #BiotechEvents #Innovation

Wildfire smoke doesn’t just harm air quality—it increases your risk of lung cancer. New research shows long-term exposure is especially dangerous for firefighters and those near wildfires. Learn how early detection helps: www.cizzlebio.com/educational-... #WildfireSmoke #LungHealth #CizzleBio

In-person connection goes a long way. Grateful to catch up with so many incredible oncology colleagues at #ASCO25. These conversations are what fuel innovation in early cancer detection. #cizzlebio #cancerresearch #biotech @ascocancer.bsky.social @conquercancer.bsky.social @cityofhope.bsky.social

Live from #ASCO25 in Chicago: Mary Jimenez of Cizzle Bio joins the Novartis reception—connecting with leaders in oncology and early detection. A proud moment for our team and mission. #CizzleBio #CancerResearch #Biotech #LungCancer #GastricCancer @novartis.bsky.social @uthealthsamda.bsky.social

We’re excited to bring Cizzle Bio’s CIZ1B and DEX-G2 cancer blood tests to the Cayman Islands in partnership with Doctors Hospital. This launch supports early and accurate detection for lung and gastric cancer in the Caribbean. 📰 www.prnewswire.com/news-release... #CizzleBio #Biotech

If you’re in town for #ASCO25, watch for our postcard around Chicago! With 95% sensitivity for Stage I lung cancer and a projected $518M Medicare savings, the CIZ1B biomarker test is reshaping early detection. 🔗 www.cizzlebio.com/press-releas... #LungCancer #Biotech #EarlyDetection #CizzleBio

A new #ASCO2025 study shows Cizzle Bio’s CIZ1B lung cancer test could save Medicare up to $518M/year. With 95% Stage I sensitivity and 96% NPV, it supports early detection and fewer unnecessary procedures. Learn more: www.cizzlebio.com/press-releas... #LungCancer #Biotech

We’ll be in Chicago for #ASCO2025! Bill, Mary, and Dr. Dalton will be on site connecting with oncology leaders and advancing our mission to deliver innovative biomarker tests for early detection—starting with lung and gastric cancer. #CancerDetection #Biotech @ascocancer.bsky.social

Grateful to attend The Inaugural Conversation & Cocktails Reception hosted by City of Hope. A powerful gathering of leaders focused on advancing cancer innovation. Cizzle Bio is proud to be part of this mission. #CityOfHope #EarlyDetection #CancerInnovation #CizzleBio @cityofhope.bsky.social

The American Lung Association is calling for broader access to biomarker testing to detect lung cancer earlier. Cizzle Bio’s CIZ1B test is leading the way in early, accurate, and accessible lung cancer diagnostics. 🧬 Read more: www.cizzlebio.com/educational-...

At AACR 2025, where innovation meets impact. Mary proudly represented Cizzle Bio with the Alamo Breast Cancer Foundation and Dr. Daniel Von Hoff, championing progress in early cancer detection and care. #AACR25 #CancerResearch #EarlyDetection @theaacr.bsky.social @cityofhope.bsky.social

New on the blog: Dr. Lary Robinson of Moffitt Cancer Center shares insights on a clinical trial evaluating the CIZ1B blood test for early lung cancer detection. Read the first post in our Clinical Thought Leadership series. 🔗 www.cizzlebio.com/clinical-tho... @moffittnews.bsky.social

🚨 How long can you live with lung cancer without treatment? Without care, survival ranges from months to just over a year, depending on type & stage. Early detection saves lives. Learn why treatment is critical & how the CIZ1B Biomarker Test helps. 📖 Read more: www.cizzlebio.com/educational-...

🚨 Cizzle Bio welcomes Dr. Ron Greeno as Chief Medical Officer! 🎉 With decades of experience in healthcare strategy & clinical leadership, Dr. Greeno will help advance our mission to detect cancer early & save lives. Learn more: www.cizzlebio.com/press-releas... #HealthcareInnovation #EarlyDetection

Cizzle Bio Welcomes Jennifer Hinkel! Jennifer joins us as Senior Consultant, Economics & Commercialization, bringing 15+ years of expertise in market access, health economics, and oncology commercialization. Excited for the future! 👏 📖 Read more: www.cizzlebio.com/press-releas...

🚀 Cizzle Bio is attending the 2025 ASCO Annual Meeting! 🧬 From May 30 – June 3 at McCormick Place, Chicago, we’ll engage with oncology leaders and discuss the future of early cancer detection. Let’s connect! 💙 🔗 www.cizzlebio.com/events/2025-... #ASCO25 #medsky #cancer #cansky #bluesky

🚀 Cizzle Bio welcomes Yolanda Heiberger as VP of Communications & Patient Education! With expertise in healthcare communications, patient education, and biotech storytelling, Yolanda will help advance awareness and early cancer detection. 🔗 Read more: www.cizzlebio.com/press-releas...

🚀 Cizzle Bio is attending the AACR Annual Meeting 2025! From April 25-30, we’ll be in Chicago engaging with top minds in cancer research & early detection. Looking forward to insightful discussions on biomarkers, precision medicine & oncology breakthroughs. 🔗 www.cizzlebio.com/events/aacr-...

Cizzle Bio Welcomes Dr. Steve Henderson! As Senior Consultant, Grant Writing & Research, Dr. Henderson brings expertise in biomedical research, clinical trials, and scientific communication to support early cancer detection innovation. 📖 Read more: www.cizzlebio.com/press-releas...

🚀 Cizzle Bio is attending the 2025 Texas BioLife Summit! On Feb 27, we’ll be in Dallas, TX, engaging with biotech leaders & investors to discuss early cancer detection & biotech innovation. Let’s connect! 📍 Hilton Anatole, Dallas, TX 🔗 Read more: www.cizzlebio.com/events/2025-...

🚀 Cizzle Bio is attending #BIOCEO2025! On Feb 10-11, we’ll be in NYC, networking with biotech executives, investors, and healthcare innovators to discuss early cancer detection and biomarker diagnostics. 📍 Marriott Marquis, NYC 🔗 Read more: www.cizzlebio.com/events/bio-c...

We’re honored to welcome Dr. Steven T. Rosen as Scientific Advisor at @cizzlebio.com! A leader in oncology with decades of experience, Dr. Rosen will help drive our mission to improve early cancer detection. 🩺 Details: www.cizzlebio.com/press-releas...

Big thanks to Dr. Lary Robinson from @moffittnews.bsky.social —a fantastic partner! Grateful for our physician advisors: Dr. Rosen, Dr. Dalton, Dr. Greeno, & Dr. Henderson. On #WorldCancerDay, we’re proud to share this study on using simple blood tests for early lung cancer detection.

Today on #WorldCancerDay, we stand united to #CloseTheCareGap. At Cizzle Bio, our mission is simple: Detect Early. Save Lives. Cancer doesn’t discriminate—but access to early detection often does. ✅ Get screened ✅ Know the signs ✅ Share this message #WorldCancerDay2025 #EarlyDetection

Connected with Debbie's Dream Foundation at #ASCOGI! Their work in raising awareness & funding for stomach cancer research is truly inspiring. Advocacy groups like these are vital in the fight against cancer. 💙 Thank you for all you do! #medsky #cansky #oncsky #cancer #cancerresearch #oncology

👋 Hello, #bluesky! We’re Cizzle Bio, a biotech company on a mission to detect cancer earlier and save lives. We develop simple, cutting-edge blood tests for #lung & GI cancers—because early detection makes all the difference. #medsky #cansky #oncsky #cancer #cancerresearch #oncology